InvestorsHub Logo
Followers 58
Posts 5857
Boards Moderated 0
Alias Born 02/09/2005

Re: T695 post# 94

Monday, 03/08/2021 8:52:48 AM

Monday, March 08, 2021 8:52:48 AM

Post# of 907
It appears an image change is in the works... VERU... putting on it's big boy pants...

“With the last two consecutive quarters for our FHC Business having set all-time historical records in terms of net revenues and gross profit, and with the last three-year compound annual growth rates for the FHC Business’ net revenues and gross profit being 60% and 83%, respectively, we think this is an ideal time to consider strategic alternatives, including the possibility of monetizing this business, as we recently did with our PREBOOST business,” said Mitchell Steiner, M.D., Chairman, President and Chief Executive Officer. “Furthermore, with the potential for five registration clinical trials in calendar year 2021 -- four for oncology indications and one for COVID-19 — it is clear that Veru has transformed itself into a premium, late-stage, clinical biopharmaceutical company, so the strategic fit with the FHC Business is not as strong as it once was.”



The dumbest people I know are those who know it all.
Malcolm Forbes

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VERU News